111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 842133-18-0 | ||
EC NO: | |||
Molecular Formula: | C24H25FO5S | ||
Molecular Weight: | 444.52 | ||
Specification: | 99.9%min | ||
Packing: | standard packaging | ||
Product description: Canagliflozin (INN, trade name Invokana or Sulisent) is a drug of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors used for the treatment of type 2 diabetes. |
|||
Uses: | Hypertension | ||
Synonyms: | (1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol;1-(¦Â-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canaglifozin; | ||
Molecular Structure: |